UPDATE: JMP Securities Starts Larimar Therapeutics (LRMR) at Market Outperform
Tweet Send to a Friend
(Updated - February 10, 2021 5:00 AM EST)
JMP Securities analyst Jonathan Wolleben initiates coverage on Larimar Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JMP Securities analyst Jonathan Wolleben initiates coverage on Larimar Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
